RxDoctor Payments Data

Thomas Wheeler, MD

Anatomic Pathology & Clinical Pathology · Conroe, TXNPI 1689679128

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $11,000 of the $13,977 with a category attached, or 78.7%. Insightec,inc accounts for 86.2% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $9,694 and has fallen 97.9% since, to $202 in 2023. Among anatomic pathology & clinical pathology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,977in general payments, 2019–2025

Across 13 payments — averaging $1075.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Insightec,inc$12K
  • Insightec,ltd$2K
  • Myriad Genetic Laboratories, Inc.$174
  • AstraZeneca$81
  • Astellas Pharma US Inc$70
  • Trisalus Life Sciences, Inc.$28

What the payments were for

  • Consulting fees$11,00079%
  • Travel & lodging$2,62419%
  • Food & beverage$3533%

General payments by program year

19
20
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,977 in reported general payments places this provider in the 95th percentile of 736 anatomic pathology & clinical pathology providers in Texas.

See all anatomic pathology & clinical pathology providers in Texas

Medicare billing

Part B allowed, 2024
$152,813
Medicare patients
797
Services billed
1,794

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Conroe

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →